Notice of Intent for Simple Plex Cartridge Kits for the ELLA Instrument

Notice of Intent for Simple Plex Cartridge Kits for the ELLA Instrument Product Service Code:

6550 NAICS Code:

325413 Place of Performance:

Bethesda, MD 20892 POTS: 25-007627 Description This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department (CCMD) intends to award a firm fixed price Purchase Order to CYVEK INC 5 Technology DR Wallingford, Connecticut 06492-1942, California 94588-3260 on a sole source basis to provide Simple Plex™ Cartridge Kits.

The Critical Care Medicine Department currently utilizes the ELLA™ Instrument to study protein biomarkers in serum, plasma from patient samples, and media samples from research experiments. In comparing previously generated data, the same technology is required. The Simple Plex™ Cartridge Kits are the only kits that are compatible with the ELLA™ Instrument. Use of any other reagents may result in erroneous testing results and may also damage the instrument.

Cyvek INC which is a part of the Bio-techne family is the sole provider and legal trademark holder of the Ella™ Instrument as well as the Simple Plex™ Cartridge Kits. To ensure accurate results, only proprietary reagents, consumables, and components must be used with the instrument. To ensure the continuity and integrity of the research, it is crucial to procure the reagents.

Products: The items below are required for this action:

Description/Product Code/Quantity: Simple Plex Cartridge Kit for 32 samples, containing GDF-15, IGFBP-2, LEPT, Resistin for use with Human Plasma/ Serum. Includes wash buffer and sample diluent SD13.

Product Number: SPCKC-PS-014674 (QTY 5) Simple Plex Cartridge Kit for 32 samples, containing BMP-9, Endothelin, FGF-21, IL-6 3rd gen for use with Human Plasma/ Serum. Includes wash buffer and sample diluent SD13.

Product Number: SPCKC-PS-014721 (QTY 5) Simple Plex Cartridge Kit for 32 samples, containing IGFBP-7, LIPO, TIMP-1 for use with Human Plasma/Serum. Includes wash buffer and sample diluent SD13.

Product Number: SPCKC-PS-014685 (QTY 5) Simple Plex Cartridge Kit for 32 samples, containing CRP, CyC, tADIPO for use with Human Plasma/Serum. Includes wash buffer and sample diluent SD13.

Product Number: SPCKC-PS-009042 (QTY 5) Simple Plex Cartridge Kit for 32 samples, containing Serpin E1/PAI-1 for use with Human Plasma/Serum. Includes wash buffer and sample diluent SD06.

Product Number: SPCKC-PS- 000343 (QTY5) Simple Plex Cartridge Kit for 32 samples, containing PC-9 for use with Human Plasma/Serum. Includes wash buffer and sample diluent SD13.

Product Number: SPCKC-PS-000321 (QTY 5) Simple Plex Stocked Cartridge Kit for 72 samples, containing MMP-9 for use with Human Plasma/Serum. Includes wash buffer and sample diluent SD13.

Product Number: ST01B-PS-000661 (QTY 2) This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested Parties: Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Comments: Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe Contract Specialist, lowet2@mail.nih.gov by the due date July 20, 2025, (8:00 pm EST) and time marked in this notice.